Discovery and Characterization of a Transient Bis(dichloromethane) Solvate of Ritonavir: A Pathway to Metastable Form IV

20 August 2024, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

This study introduces a new solid form of the antiviral drug ritonavir, specifically a bis(dichloromethane) solvate. The novel solvate was crystallized from a dichloromethane solution with hexane. The solvent is easily lost from the crystal lattice at room temperature, resulting in a known metastable anhydrate form, ritonavir Form IV. The desolvation process was monitored by powder X-ray diffraction over 6 hours using multiple scans. Indexing, along with unit-cell refinement by Pawley fit, were performed for both the novel ritonavir-bis(dichloromethane) solvate and metastable ritonavir Form IV. The presented desolvation of the novel solvate provides a simplified pathway for the isolation of metastable Form IV.

Keywords

Ritonavir
Solvate
Polymorphism
Crystallization

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.